Efficient production of recombinant cystatin C using a peptide-tag, 4AaCter, that facilitates formation of insoluble protein inclusion bodies in Escherichia coli
Authors:
- 8 February 2013
- journal article
- research article
- Published by Elsevier in Protein Expression and Purification
- Vol. 88 (2) , 230-234
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin CClinical Journal of the American Society of Nephrology, 2008
- Towards novel anti-cancer strategies based on cystatin functionCancer Letters, 2006
- Cystatin C as a marker of GFR—history, indications, and future researchClinical Biochemistry, 2005
- Early detection of acute renal failure by serum cystatin CKidney International, 2004
- Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysisAmerican Journal of Kidney Diseases, 2002
- Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subjectsClinica Chimica Acta, 1999
- Serum Cystatin C as an Endogenous Marker of the Renal Function – a ReviewClinical Chemistry and Laboratory Medicine (CCLM), 1999
- Renal handling of radiolabelled human cystatin C in the ratScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Inhibitory effects of recombinant human cystatin C on human coronavirusesAntimicrobial Agents and Chemotherapy, 1991
- Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation.Journal of Experimental Medicine, 1987